|
Batch review performed by medacta regulatory affairs department on 19 may 2020: lot 182543: (b)(4) items manufactured and released on 18-sep-2018.Expiration date: 2023-09-04.No anomalies found related to the problem.To date, (b)(4) items of the same lot have been already sold without other similar reported event.Clinical evaluation performed by medical affairs manager: femoral fracture occurred few days after cementless total hip arthroplasty.According to the report, this event was due to a suboptimal implant position.During rehabilitation period, a sudden movement on a weakened bone due to normal femoral preparation may favour the occurrence of early fracture.There is no reason to suspect a faulty device.
|